August 24, 2010 — Exposure to acyclovir or valacyclovir in the first trimester of pregnancy is not associated with an increased risk for major birth defects, according to the results of a large, ...

Oral acyclovir has been demonstrated to prevent reactivation of herpes simplex virus (HSV) infections when administered prophylactically to autologous bone marrow transplant (BMT) recipients or ...

An analysis of data from Denmark finds no associated increased risk of major birth defects for mothers who were exposed during the first trimester of pregnancy to the antiviral drugs acyclovir, ...

Please provide your email address to receive an email when new articles are posted on . After a standard course of IV acyclovir therapy for laboratory-confirmed herpes simplex encephalitis, further ...

Please provide your email address to receive an email when new articles are posted on . The current lineup of oral antivirals, such as acyclovir, famciclovir and valacyclovir, continue to effectively ...

A higher risk of birth defects is not caused by using certain antiviral drugs, concludes a new study. An analysis of data from Denmark found no associated increased risk of major birth defects for ...

New York, April 20, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Herpes Simplex Virus Treatment Market Size, Share & Industry Trends Analysis Report By Drug ...

Of all the drugs used to treat herpes, acyclovir is the most common. So, how does it work? The devil is in the details ... and the details are fascinating. Earlier this month I wrote about an ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Reduced intensity conditioning regimens were developed to reduce the toxicities associated with HSCT. Incorporating alemtuzumab (Campath-1H ®), a humanized monoclonal antibody to CD52, in reduced ...

An analysis of data from Denmark finds no associated increased risk of major birth defects for mothers who were exposed during the first trimester of pregnancy to the antiviral drugs acyclovir, ...